FTY720 Reduces Lipid Accumulation by Upregulating ABCA1 through Liver X Receptor and Sphingosine Kinase 2 Signaling in Macrophages

• Published in: International journal of molecular sciences 2022-11, Vol.23 (23), p.14617
• Main Authors: Tachibana, Koki, Kusumoto, Kohshi, Ogawa, Mai, Ando, Hidenori, Shimizu, Taro, Ishima, Yu, Ishida, Tatsuhiro, Okuhira, Keiichiro
• Format: Article
• Language: English
• Subjects: ABCA1; ABCA1 protein; Accumulation; Acetylation; Animals; Apolipoprotein E; Arteriosclerosis; Atherosclerosis; Atherosclerosis - metabolism; ATP Binding Cassette Transporter 1 - genetics; ATP Binding Cassette Transporter 1 - metabolism; ATP-binding protein; Cholesterol; Cholesterol - metabolism; FDA approval; Fingolimod Hydrochloride - therapeutic use; Foam Cells - metabolism; FTY720; Genes; Histone H3; Histones; Kinases; Lipids; Liver; liver X receptor; Liver X receptors; Liver X Receptors - genetics; Liver X Receptors - metabolism; Lysine; Macrophages; Mice; Multiple sclerosis; Mutation; Phosphotransferases (Alcohol Group Acceptor) - metabolism; Protein expression; Proteins; Sphingosine kinase; sphingosine kinase 2
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms232314617

Formation of foam cells as a result of excess lipid accumulation by macrophages is a pathological hallmark of atherosclerosis. Fingolimod (FTY720) is an immunosuppressive agent used in clinical settings for the treatment of multiple sclerosis and has been reported to inhibit atherosclerotic plaque development. However, little is known about the effect of FTY720 on lipid accumulation leading to foam cell formation. In this study, we investigated the effects of FTY720 on lipid accumulation in murine macrophages. FTY720 treatment reduced lipid droplet formation and increased the expression of ATP-binding cassette transporter A1 (ABCA1) in J774 mouse macrophages. FTY720 also enhanced the expression of liver X receptor (LXR) target genes such as FASN, APOE, and ABCG1. In addition, FTY720-induced upregulation of ABCA1 was abolished by knockdown of sphingosine kinase 2 (SphK2) expression. Furthermore, we found that FTY720 treatment induced histone H3 lysine 9 (H3K9) acetylation, which was lost in SphK2-knockdown cells. Taken together, FTY720 induces ABCA1 expression through SphK2-mediated acetylation of H3K9 and suppresses lipid accumulation in macrophages, which provides novel insights into the mechanisms of action of FTY720 on atherosclerosis.